Cargando…

Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity

Estimating the dissolution behavior of a solid in the nasal mucus is challenging for solid dosage forms designed for the nasal application as the solid dissolves into nasal mucus and permeates through the mucosa. In the current study, the dissolution behavior of powders in the artificial nasal fluid...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Daisuke, Yamashita, Ayari, To, Hideto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697526/
https://www.ncbi.nlm.nih.gov/pubmed/36365167
http://dx.doi.org/10.3390/pharmaceutics14112350
_version_ 1784838585778700288
author Inoue, Daisuke
Yamashita, Ayari
To, Hideto
author_facet Inoue, Daisuke
Yamashita, Ayari
To, Hideto
author_sort Inoue, Daisuke
collection PubMed
description Estimating the dissolution behavior of a solid in the nasal mucus is challenging for solid dosage forms designed for the nasal application as the solid dissolves into nasal mucus and permeates through the mucosa. In the current study, the dissolution behavior of powders in the artificial nasal fluid was investigated using a 3D-printed chamber system to establish in vitro evaluation system for the dissolution of solid formulations that can simulate the intranasal environment in vivo. The dissolution rates of the five model drugs correlated with their solubility (r(2) = 0.956, p < 0.01). The permeation rate of drugs across the Calu-3 cell layers after powder application depends on the membrane permeability of the drug. An analysis of membrane permeability considering the dissolution of powders showed the possibility of characterizing whether the drug in the powder was dissolution-limited or permeation-limited. This suggests that critical information can be obtained to understand which mechanism is more effective for the improvement of drug absorption from powders. This study indicates that the elucidation of drug dissolution behavior into nasal mucus is an important factor for the formulation of nasal powders and that the in vitro system developed could be a useful tool.
format Online
Article
Text
id pubmed-9697526
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96975262022-11-26 Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity Inoue, Daisuke Yamashita, Ayari To, Hideto Pharmaceutics Article Estimating the dissolution behavior of a solid in the nasal mucus is challenging for solid dosage forms designed for the nasal application as the solid dissolves into nasal mucus and permeates through the mucosa. In the current study, the dissolution behavior of powders in the artificial nasal fluid was investigated using a 3D-printed chamber system to establish in vitro evaluation system for the dissolution of solid formulations that can simulate the intranasal environment in vivo. The dissolution rates of the five model drugs correlated with their solubility (r(2) = 0.956, p < 0.01). The permeation rate of drugs across the Calu-3 cell layers after powder application depends on the membrane permeability of the drug. An analysis of membrane permeability considering the dissolution of powders showed the possibility of characterizing whether the drug in the powder was dissolution-limited or permeation-limited. This suggests that critical information can be obtained to understand which mechanism is more effective for the improvement of drug absorption from powders. This study indicates that the elucidation of drug dissolution behavior into nasal mucus is an important factor for the formulation of nasal powders and that the in vitro system developed could be a useful tool. MDPI 2022-10-31 /pmc/articles/PMC9697526/ /pubmed/36365167 http://dx.doi.org/10.3390/pharmaceutics14112350 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Inoue, Daisuke
Yamashita, Ayari
To, Hideto
Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
title Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
title_full Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
title_fullStr Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
title_full_unstemmed Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
title_short Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
title_sort development of in vitro evaluation system for assessing drug dissolution considering physiological environment in nasal cavity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697526/
https://www.ncbi.nlm.nih.gov/pubmed/36365167
http://dx.doi.org/10.3390/pharmaceutics14112350
work_keys_str_mv AT inouedaisuke developmentofinvitroevaluationsystemforassessingdrugdissolutionconsideringphysiologicalenvironmentinnasalcavity
AT yamashitaayari developmentofinvitroevaluationsystemforassessingdrugdissolutionconsideringphysiologicalenvironmentinnasalcavity
AT tohideto developmentofinvitroevaluationsystemforassessingdrugdissolutionconsideringphysiologicalenvironmentinnasalcavity